Solumedrol
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
2336 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | D008223 | — | C85.9 | 33 | 93 | 40 | 4 | 15 | 162 |
| Leukemia | D007938 | — | C95 | 16 | 68 | 21 | 7 | 9 | 107 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 11 | 47 | 24 | 9 | 6 | 85 |
| Prostatic neoplasms | D011471 | — | C61 | 12 | 34 | 28 | 5 | 9 | 79 |
| Syndrome | D013577 | — | — | 8 | 32 | 10 | 10 | 19 | 72 |
| Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 3 | 17 | 16 | 18 | 5 | 58 |
| Covid-19 | D000086382 | — | U07.1 | 3 | 9 | 24 | 7 | 17 | 56 |
| Kidney transplantation | D016030 | — | — | 5 | 19 | 14 | 20 | 3 | 56 |
| Asthma | D001249 | EFO_0000270 | J45 | 2 | 9 | 10 | 16 | 16 | 52 |
| Inflammation | D007249 | MP_0001845 | — | 3 | 10 | 15 | 14 | 14 | 52 |
Show 379 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Graft vs host disease | D006086 | — | D89.81 | 18 | 39 | 16 | — | 7 | 71 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 15 | 48 | 14 | — | 2 | 68 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 12 | 40 | 15 | — | 5 | 64 |
| Myelodysplastic syndromes | D009190 | — | D46 | 10 | 39 | 2 | — | 4 | 49 |
| B-cell lymphoma | D016393 | — | — | 14 | 26 | 5 | — | 2 | 37 |
| Plasma cell neoplasms | D054219 | — | — | 9 | 16 | 6 | — | 6 | 37 |
| Preleukemia | D011289 | — | — | 4 | 22 | 2 | — | 3 | 27 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 5 | 19 | 3 | — | 1 | 26 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 10 | 18 | 2 | — | 1 | 24 |
| Alcoholic hepatitis | D006519 | EFO_1001345 | K70.1 | 1 | 6 | 9 | — | 7 | 22 |
Show 219 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myeloproliferative disorders | D009196 | — | D47.1 | 5 | 18 | — | — | 2 | 23 |
| Myelodysplastic-myeloproliferative diseases | D054437 | — | — | 1 | 11 | — | — | 2 | 14 |
| Mantle-cell lymphoma | D020522 | — | C83.1 | 3 | 10 | — | — | 1 | 13 |
| B-cell lymphoma marginal zone | D018442 | — | C88.4 | 3 | 9 | — | — | 1 | 12 |
| T-cell lymphoma | D016399 | — | — | 5 | 9 | — | — | — | 11 |
| Myeloid leukemia chronic-phase | D015466 | — | — | 2 | 8 | — | — | 1 | 10 |
| Myelomonocytic leukemia chronic | D015477 | — | C93.1 | 3 | 7 | — | — | 1 | 10 |
| T-cell lymphoma peripheral | D016411 | — | — | 4 | 8 | — | — | — | 9 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 2 | 8 | — | — | — | 9 |
| Myeloid leukemia accelerated phase | D015465 | — | — | 2 | 6 | — | — | 1 | 8 |
Show 224 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pathologic dilatation | D004108 | — | — | 1 | — | — | — | 4 | 5 |
| Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | 1 | — | — | — | 3 | 4 |
| Intestinal diseases | D007410 | — | K63.9 | 1 | — | — | — | 2 | 3 |
| Therapeutic equivalency | D013810 | — | — | 3 | — | — | — | — | 3 |
| Precancerous conditions | D011230 | — | — | 2 | — | — | — | — | 2 |
| Bone fractures | D050723 | EFO_0003931 | T14.8 | 1 | — | — | — | 1 | 2 |
| Friedreich ataxia | D005621 | Orphanet_95 | G11.11 | 2 | — | — | — | — | 2 |
| Retinal perforations | D012167 | EFO_1001028 | — | 1 | — | — | — | 1 | 2 |
| Fever | D005334 | — | R50.9 | 1 | — | — | — | 1 | 2 |
| Tinnitus | D014012 | — | H93.1 | 1 | — | — | — | 1 | 2 |
Show 26 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Morton neuroma | D000070607 | — | G57.6 | — | — | — | — | 3 | 3 |
| Rotator cuff injuries | D000070636 | — | M75.1 | — | — | — | — | 3 | 3 |
| Regeneration | D012038 | — | — | — | — | — | — | 3 | 3 |
| Uveomeningoencephalitic syndrome | D014607 | Orphanet_3437 | H20.82 | — | — | — | — | 3 | 3 |
| Mycoplasma infections | D009175 | — | — | — | — | — | — | 2 | 2 |
| Pleuropneumonia | D011001 | — | — | — | — | — | — | 2 | 2 |
| Keratoconjunctivitis | D007637 | — | H16.2 | — | — | — | — | 2 | 2 |
| Cicatrix | D002921 | — | L90.5 | — | — | — | — | 2 | 2 |
| Blood pressure | D001794 | EFO_0004325 | — | — | — | — | — | 2 | 2 |
| Vitiligo | D014820 | EFO_0004208 | L80 | — | — | — | — | 2 | 2 |
Show 172 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
128 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use